Trials that use: Covariate adjustment
5,848 results
- Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC): Complete Statistical AnalysisIndependent statistical analysis of Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures: Complete Statistical AnalysisIndependent statistical analysis of Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00594945).
- Study of Intraoperative Radiotherapy for Patients With Large Brain Metastases Treated With Neurosurgical Resection: Complete Statistical AnalysisIndependent statistical analysis of Study of Intraoperative Radiotherapy for Patients With Large Brain Metastases Treated With Neurosurgical Resection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen: Complete Statistical AnalysisIndependent statistical analysis of Study of Intravenous Ampion in Adult COVID-19 Patients Requiring Supplemental Oxygen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers: Complete Statistical AnalysisIndependent statistical analysis of Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers: Complete Statistical AnalysisIndependent statistical analysis of Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer’s Disease Dementia: Complete Statistical AnalysisIndependent statistical analysis of Study of Lemborexant for Irregular Sleep-Wake Rhythm Disorder and Mild to Moderate Alzheimer's Disease Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors: primary endpoint results, effect estimate with confidence interval, sample-size…
- Study of Long-Acting Acetaminophen in Postoperative Dental Pain: Complete Statistical AnalysisIndependent statistical analysis of Study of Long-Acting Acetaminophen in Postoperative Dental Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01960114).
- Study of Lunesta Versus Placebo for Sleep Problems Related to Smoking Cessation and Zyban: Complete Statistical AnalysisIndependent statistical analysis of Study of Lunesta Versus Placebo for Sleep Problems Related to Smoking Cessation and Zyban: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of LY3016859 in Participants With Diabetic Nephropathy: Complete Statistical AnalysisIndependent statistical analysis of Study of LY3016859 in Participants With Diabetic Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01774981).
- Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring: Complete Statistical AnalysisIndependent statistical analysis of Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGFR Reusable Sensor With Disposable Adhesive Ring: primary endpoint results, effect estimate…
- Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Multiple Doses of Saxagliptin (BMS-477118): Complete Statistical AnalysisIndependent statistical analysis of Study of Multiple Doses of Saxagliptin (BMS-477118): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00950599).
- Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis: Complete Statistical AnalysisIndependent statistical analysis of Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Nasal Insulin to Fight Forgetfulness – Device Study: Complete Statistical AnalysisIndependent statistical analysis of Study of Nasal Insulin to Fight Forgetfulness - Device Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03857321).
- Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Study of Octagam (Intravenous Immunoglobulin [IVIG]) 10% on the Treatment of Mild to Moderate Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of OMNI Surgical System and iStent for Eyes With OAG (Trident): Complete Statistical AnalysisIndependent statistical analysis of Study of OMNI Surgical System and iStent for Eyes With OAG (Trident): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Oral ALXN1840 at 2 Dose Strengths in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Study of Oral ALXN1840 at 2 Dose Strengths in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion: Complete Statistical AnalysisIndependent statistical analysis of Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.: Complete Statistical AnalysisIndependent statistical analysis of Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of PEG-Intron for Plexiform Neurofibromas: Complete Statistical AnalysisIndependent statistical analysis of Study of PEG-Intron for Plexiform Neurofibromas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00396019).
- Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-052): Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-052): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355): Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355): primary endpoint results, effect estimate…
- Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177): Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177): primary endpoint results, effect estimate…
- Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689): Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689): primary endpoint results, effect estimate…
- Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02998268).
- Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Participants With Non-Small Cell Lung Cancer Who Have Not Been…
- STUDY OF PF-06882961 IN PARTICIPANTS WITH AND WITHOUT VARYING DEGREES OF HEPATIC IMPAIREMENT: Complete Statistical AnalysisIndependent statistical analysis of STUDY OF PF-06882961 IN PARTICIPANTS WITH AND WITHOUT VARYING DEGREES OF HEPATIC IMPAIREMENT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia: Complete Statistical AnalysisIndependent statistical analysis of Study of Pitavastatin in Elderly Patients With Primary Hypercholesterolemia or Combined Dyslipidemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injury: Complete Statistical AnalysisIndependent statistical analysis of Study of PK and Safety of the LicartTM Topical System in Pediatric and Adult Participants With Minor Soft Tissue Injury: primary endpoint results, effect estimate with confidence interval,…
- Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas: Complete Statistical AnalysisIndependent statistical analysis of Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant: Complete Statistical AnalysisIndependent statistical analysis of Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment: Complete Statistical AnalysisIndependent statistical analysis of Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of Prasugrel in Korean Healthy Male Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Study of Prasugrel in Korean Healthy Male Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01591317).
- Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer: primary…
- Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting: Complete Statistical AnalysisIndependent statistical analysis of Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting: primary endpoint results, effect estimate with confidence…
- Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia: Complete Statistical AnalysisIndependent statistical analysis of Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults: Complete Statistical AnalysisIndependent statistical analysis of Study of RSVpreF Vaccination and RSV Challenge in Healthy Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04785612).
- Study of Ruxolitinib in Colorectal Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Ruxolitinib in Colorectal Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02119676).
- Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1): Complete Statistical AnalysisIndependent statistical analysis of Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02117479).
- Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016): Complete Statistical AnalysisIndependent statistical analysis of Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042): Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer: primary endpoint results, effect estimate with confidence…
- Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer.: Complete Statistical AnalysisIndependent statistical analysis of Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination With Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF…
- Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260): Complete Statistical AnalysisIndependent statistical analysis of Study of Sitagliptin for the Treatment of Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0431-260): primary endpoint results, effect estimate with confidence interval, sample-size planning…